(0)
System further enhances user experience and helps address the evolving challenges of the intensive care unit
TrueVue digital health solutions simplify connectivity with critical hospital data systems and offer actionable insights to support CRRT quality improvement programs
PrisMax 2 system enables ECCO
2R therapy with
PrismaLung+ blood-gas exchanger, currently available in select markets in western Europe
Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the global launch of
PrisMax
2, the latest version of the company s next-generation platform.
PrisMax 2 is designed to help simplify delivery of continuous renal replacement therapy (CRRT) and other organ support therapies, while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU). The